The U.S. Food and Drug Administration (FDA) is recommending that the breast cancer indication for Avastin be removed from its label “because the drug has not been shown to be safe and effective for that use.” Read more here.
FDA recommends removing Avastin’s breast cancer indication
Most Recent Content
For Nurse Practitioners
Will Omicron Be More Contagious Than Delta?
If the first thing you heard about the omicron variant over the holiday weekend was that it is bad news, the second thing was...
